TriSalus Life Sciences, Inc. (TLSI) Revenue 2022–2025
TriSalus Life Sciences, Inc. (TLSI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$45.2MFY2025 · since FY2022: $12.4M → $45.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $45.2M | +53.4% |
| FY2024 | $29.4M | +59.0% |
| FY2023 | $18.5M | +49.3% |
| FY2022 | $12.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI Net incomeTLSI Net marginTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →